Back to Journals » Drug Design, Development and Therapy » Volume 6

A first-in-man study to evaluate the safety, tolerability, and pharmacokinetics of pasireotide (SOM230), a multireceptor-targeted somatostatin analog, in healthy volunteers

Total article views   HTML views PDF downloads Totals
13,351 Dovepress* 11,236+ 2,097 13,333
PubMed Central* 2,115 892 3,007
Totals 13,351 2,989 16,340
*Since 19 April 2012
+Since July 2016
Total mentioned Facebook Delicious Reddit Twitter Others
2 0 0 0 1 1

View citations on PubMed Central and Google Scholar